| 摘要 |
<p>Novel farnesyl transferase inhibitors of general formula (I), preparation thereof and pharmaceutical compositions containing same. In general formula (I), R1 is Y-S-A1 (where Y is a hydrogen atom, an amino acid residue, a fatty acid residue, or an alkyl or alkoxycarbonyl radical, and A1 is a C1-4 alkylene radical optionally α-substituted in the ⊃C(X1)(Y1) grouping by an amino, alkylamino, alkanoylamino or alkoxycarbonylamino radical wherein the alkyl or alkanoyl portion contains 1-6 carbon atoms; each of X1 and Y1 is a hydrogen atom or X1 and Y1, taken together with the carbon atom to which they are attached, form a ⊃C=O grouping; R'1 is hydrogen or a C1-6 alkyl radical; X is an oxygen or sulphur atom; R2 is a C1-6 alkyl, alkenyl or alkynyl radical optionally substituted by hydroxy, alkoxy, mercapto, alkylthio, alkylsulphinyl or alkylsulphonyl, with the proviso that when R2 is an alkyl radical substituted by a hydroxy radical, then R2 and the α carboxy radical can form a lactone; R'2 is hydrogen or a C1-6 alkyl radical; and R is a hydrogen atom, an optionally substituted alkyl radical or an optionally substituted phenyl radical. Said novel products have anticancer properties.</p> |
